GlassScriptPhysician profile
Lisa A Stephens
NPI 1831590769
$5,347.39
in general payments reported to CMS, 2019-2025
40 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,339 · 2022: $1,188 · 2023: $939 · 2024: $327 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.22 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,141.38 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $913.94 | 2021 | |
| Amgen INC. | $265.43 | 2021-2024 | Repatha, Otezla |
| Lilly USA, LLC | $249.92 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $211.51 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.68 | 2021-2022 | |
| Novo Nordisk INC | $190.25 | 2021-2025 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $185.09 | 2021-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $177.45 | 2021-2023 | Spravato, Xarelto |
| Otsuka America Pharmaceutical, INC. | $165.87 | 2021-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.56 | 2021-2025 | Xifaxan, Trulance |
| Pfizer INC. | $128.20 | 2021-2024 | |
| Glaxosmithkline, LLC. | $125.57 | 2021-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $114.11 | 2022 | |
| Amarin Pharma, INC. | $107.77 | 2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.